Opiant Pharmaceuticals, Inc. EBITDA 2014-2022 | OPNT

Opiant Pharmaceuticals, Inc. ebitda from 2014 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Opiant Pharmaceuticals, Inc. Annual EBITDA
(Millions of US $)
2021 $6
2020 $-2
2019 $11
2018 $-21
2017 $
2017 $7
2016 $-8
2015 $-7
2014 $-11
2013 $-8
Opiant Pharmaceuticals, Inc. Quarterly EBITDA
(Millions of US $)
2022-09-30 $-10
2022-06-30 $-11
2022-03-31 $-12
2021-12-31 $2
2021-09-30 $4
2021-06-30 $2
2021-03-31 $-2
2020-12-31 $-0
2020-09-30 $1
2020-06-30 $-0
2020-03-31 $-2
2019-12-31 $1
2019-09-30 $11
2019-06-30 $1
2019-03-31 $-2
2018-12-31 $-10
2018-09-30 $-1
2018-06-30 $-1
2018-03-31 $-9
2017-12-31
2017-10-31 $-6
2017-09-30 $-3
2017-07-31
2017-06-30 $0
2017-04-30 $-3
2017-03-31 $-3
2017-01-31 $11
2016-10-31 $-1
2016-07-31
2016-04-30 $0
2016-01-31 $4
2015-10-31 $-11
2015-07-31
2015-04-30 $-2
2015-01-31 $-3
2014-10-31 $-1
2014-07-31
2014-04-30 $-0
2014-01-31 $-5
2013-10-31 $-1